Metabolite List
metabolites which its exact mass nearly 356.1783 with tolerance error 0.01 da.
N-(1-adamantyl)-4-(2,4-difluorophenyl)-1H-pyrrole-2-carboxamide (BioCAD00000651448)
Formula: C21H22F2N2O (Exact Mass: 356.17)
N-(2-adamantyl)-4-(2,4-difluorophenyl)-1H-pyrrole-2-carboxamide (BioCAD00000651450)
Formula: C21H22F2N2O (Exact Mass: 356.17)
N-[(2-benzyl-2-azabicyclo[2.1.1]hexan-1-yl)methyl]-2-(2,5-difluorophenyl)acetamide (BioCAD00000678327)
Formula: C21H22F2N2O (Exact Mass: 356.17)
2,4-Bis(2-fluorophenyl)-5-methyl-3-azabicyclo[3.3.1]nonan-9-one oxime (BioCAD00000726052)
Formula: C21H22F2N2O (Exact Mass: 356.17)
Valopicitabine (BioCAD00000750562)
Formula: C15H24N4O6 (Exact Mass: 356.1696)
The 3-O-valine ester prodrug of the nucleoside analog 2'-C-methylcytidine with anti-hepatitis C virus (HCV) activity. Upon administration, valopicitabine is converted into 2'-C-methylcytidine; upon phosphorylation into its 5-triphosphate form, this metabolite inhibits viral RNA chain elongation and viral RNA-dependent RNA polymerase activity. This blocks viral production of HCV RNA and thus viral replication. [from NCI] Valopicitabine is the 3-O-valine ester prodrug of the nucleoside analog 2'-C-methylcytidine with anti-hepatitis C virus (HCV) activity. Upon administration, valopicitabine is converted into 2'-C-methylcytidine; upon phosphorylation into its 5-triphosphate form, this metabolite inhibits viral RNA chain elongation and viral RNA-dependent RNA polymerase activity. This blocks viral production of HCV RNA and thus viral replication.